AVTE insider transaction filings
Aerovate Therapeutics, Inc. — 13 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2024-08-02. Screen AVTE transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for AVTE between 2026-06-11 and 2026-09-09. The table below lists the most recent filings on record.
Recent Form 4 filings — Aerovate Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2024-08-02 | 4 | Dake Benjamin T — SEE REMARKS | Option exercise (M): 11,454 @ $1.74 · Option exercise (M): 1,507 @ $1.74 · Option exercise (M): 906 (derivative) @ $0 · Option exercise (M): 10,548 (derivative) @ $0 · Option exercise (M): 1,507 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 928,110 @ $1.67 | EDGAR |
| 2024-06-14 | 4 | Verwijs Marinus — CHIEF TECHNICAL OFFICER | Option exercise (M): 10,600 @ $14.59 · Sale (S): 10,600 @ $25 · Option exercise (M): 10,600 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Gillies Hunter — CHIEF MEDICAL OFFICER | Option exercise (M): 6,000 @ $2.14 · Sale (S): 6,000 @ $24.50 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Eldridge George A — SEE REMARKS | Option exercise (M): 15,000 @ $2.14 · Sale (S): 15,000 @ $25.03 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | GRAYZEL DAVID S. — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Katabi Maha — Director, 10% owner | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Resnick Joshua — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Dable Habib J — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Dorval Allison — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Iwicki Mark T — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner RA Capital Nexus Fund, L.P. — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Santel Donald J — Director | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
Recent 8-K events — Aerovate Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement | EDGAR |
| 2026-06-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-11 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-01 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-04-02 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AVTE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →